type here...

Life Sciences Voice Rising Stars Award

Life Sciences Voice Rising Stars Award recognizes the rising stars in the Life Sciences industry. These are leaders who are bringing positive change and enabling transformation in the life sciences sector. They are the industry's rising stars, working on important initiatives and driving change in the industry. Anyone from the manufacturer's side - pharma, medical device, biotech, specialty, consumer health, animal health - or vendor side is eligible to apply.

Nominate Now!

Award Benefits

  • Prestigious recognition as a rising star in the Life Sciences industry.
  • High visibility digital presence with a dedicated web page profile for each winner and their organization.
  • Personalized promotion for each nominee and winner across social media.
  • Logo, graphics, and social media promotional material, along with rights to include award recognition on LinkedIn profile.
  • Speaking and thought leadership opportunities - published articles, podcasts, and in-person events.

Submission Criteria

Anyone from the industry can nominate up to three individuals. More than one person can be nominated from an organization. Self-nomination is allowed.

Timelines

  • Nomination Submission Deadline: 10th October, 2024
  • Winners Contacted: By 24th October, 2024
  • Announcement and PR: 15th November, 2024

How to Apply

  • Thanks for your interest in the LSV Rising Stars Award. The nominations are currently closed. Please check back later.

Editor Picks

IntraOp Announces Phase II Trial for Carcinoma Therapy

Clinical Editorial Team - 0
IntraOp Medical Corporation has announced the second phase of the first-ever Electron...
Read more

Data shows Pfizer’s RSV vaccines administered in pregnant women protect newborns

Clinical Editorial Team - 0
Clinical trial data revealed that Pfizer’s RSV (respiratory syncytial virus) vaccine has...
Read more

Novocure’s TTFields Misses the Mark in Phase 3 Ovarian Cancer Trial

Clinical Editorial Team - 0
In a striking departure from earlier this year's promising findings, Novocure's groundbreaking...
Read more

Must Read

Merck Signs $493M Agreement to Use Cyprumed’s Oral Peptide Platform

Commercial Editorial Team - 0
Merck & Co. is taking a significant step toward transforming its peptide therapies into...
Read more

The late-stage research of Bristol Myers’ heart disease medication falls short of its primary objectives

Clinical Editorial Team - 0
Bristol Myers Squibb disclosed that its drug stavartanate did not successfully improve functional capacity...
Read more

J&J MedTech presents the first Ottava surgical robot clinical cases

Technology Editorial Team - 0
Johnson & Johnson MedTech successfully conducted the initial clinical use of Ottava surgical robot...
Read more

Hot Topics

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Contact us: reachout(at)lifescivoice.com

Follow Us

© Copyright - Life Sciences Voice